Kojima, Y., Downing, K., Kundu, R., Miller, C., Dewey, F., Lancero, H., . . . Leeper, N. J. (2019). Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Invest.
シカゴスタイル引用形Kojima, Yoko, et al. "Cyclin-dependent Kinase Inhibitor 2B Regulates Efferocytosis and Atherosclerosis." J Clin Invest 2019.
MLA引用形式Kojima, Yoko, et al. "Cyclin-dependent Kinase Inhibitor 2B Regulates Efferocytosis and Atherosclerosis." J Clin Invest 2019.
警告: この引用は必ずしも正確ではありません.